Lilly and Investor Group Form New Critical Care Company BioCritica
- Details
- Category: Eli Lilly and Company

Sanofi's Commitment to Research and Identify Treatments for Cancer Patients
- Details
- Category: Sanofi

SUTENT® Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
- Details
- Category: Pfizer

Takeda to Acquire Nycomed - Transaction will Transform Takeda's Global Business
- Details
- Category: Takeda

Roche to present significant progress in advanced skin, lung and ovarian cancers at ASCO
- Details
- Category: Roche

Shire to establish new Regenerative Medicine business unit through cash acquisition of Advanced BioHealing, Inc.
- Details
- Category: Shire

Pfizer To Present New Research From Fifteen Compounds
- Details
- Category: Pfizer

More Pharma News ...
- Patrick Dempsey Teams up With Breakaway from Cancer(R)
- New drug applications submitted in the United States and Europe for vemurafenib in advanced skin cancer
- Pharmaceutical industry and university create Manchester Collaborative Centre for Inflammation Research
- Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study
- Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment versus generic Clopidogrel
- Sanofi-aventis and Medicines for Malaria Venture Join Forces to Develop Innovative Malaria Drugs
- Novartis gains FDA approval for Afinitor®